Synthetic Extracellular Volume in Cardiac Magnetic Resonance Without Blood Sampling: a Reliable Tool to Replace Conventional Extracellular Volume

Author:

Chen Wensu12ORCID,Doeblin Patrick134ORCID,Al-Tabatabaee Sarah13,Klingel Karin5ORCID,Tanacli Radu134ORCID,Jakob Weiß Karl134ORCID,Stehning Christian6,Patel Amit R.7,Pieske Burkert134,Zou Jiangang8ORCID,Kelle Sebastian134ORCID

Affiliation:

1. Department of Internal Medicine/Cardiology, German Heart Center Berlin, Germany (W.C., P.D., S.A.-T., R.T., K.J.W., B.P., S.K.).

2. Department of Cardiology, Affiliated Hospital of Xuzhou Medical University, China (W.C.).

3. Department of Internal Medicine/Cardiology, Charité University Medicine, Campus Virchow Clinic, Berlin, Germany (P.D., S.A.-T., R.T., K.J.W., B.P., S.K.).

4. DZHK (German Center for Cardiovascular Research), Partner Site Berlin, Germany (P.D., R.T., K.J.W., B.P., S.K.).

5. Department of Cardiopathology, Institute for Pathology and Neuropathology, University Hospital Tuebingen, Germany (K.K.).

6. Philips Clinical Science, Hamburg, Germany (C.S.).

7. Department of Medicine and Radiology, University of Chicago, IL (A.R.P.).

8. Department of Cardiology, First Affiliated Hospital, Nanjing Medical University, China (J.Z.).

Abstract

Background: The calculation of extracellular volume (ECV) in cardiac magnetic resonance requires hematocrit, limiting its applicability in clinical practice. Based on the linear relationship between hematocrit and blood T1 relaxivity, a synthetic ECV could be estimated without a blood sample. We aim to develop and test regression models for synthetic ECV without blood sampling in 1.5-T and 3.0-T scanners. Methods: A total of 1101 subjects who underwent cardiac magnetic resonance scanning with native and postcontrast T1 mapping and venous hematocrit within 24 hours were retrospectively enrolled. Subjects were randomly split into derivation (n=550) and validation (n=551) subgroups for each scanner. Different regression models were derived controlling for sex, field strength, and left ventricle/right ventricle blood pool and validated in the validation group. We performed additional validation analyses in subgroups of patients with histological validation (n=17), amyloidosis (n=29), anemia (n=185), and reduced ejection fraction (n=322). Results: In the derivation group, 8 specific models and 2 common estimate models were derived. In the validation group, using specific models, synthetic ECV had high agreement with conventional ECV (R 2 , 0.87; P <0.0001 and R 2 , 0.88, P <0.0001; −0.16% and −0.10%, left ventricle and right ventricle model, respectively). Common models also performed well (R 2 , 0.88; P <0.0001 and R 2 , 0.89, P <0.0001; −0.21% and −0.18%, left ventricle and right ventricle model, respectively). Histological validation demonstrated equal performance of synthetic and measured ECV. Synthetic ECV as calculated by the common model showed a bias in the anemia cohort significantly reduced by the specific model (−2.45 to −1.28, right ventricle common and specific model, respectively). Conclusions: Synthetic ECV provided a promising way to calculate ECV without blood sampling. Specific models could provide the most accurate value, while common models could be more suitable in routine clinical practice because of their simplicity while maintaining adequate accuracy.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging

Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3